Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
Catalog No. | Product Name | Size | List Price (US$) | Quantity |
---|
Price/availability/specifications subject to change without notice. Unless otherwise indicated, our catalog and customized products are for research use only and not intended for human or animal diagnostic or therapeutic use.
Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
Background Information:
PD-1 Inhibitor 16 (Aurigene Compound 16) (extracted from Patent (compound 16, ref 1)) is an orally bioavailable small molecule peptidomimetic inhibitor of the immune checkpoint regulatory proteins PD-I/PD-L1 (programmed cell death -1/programmed cell death ligand-1) interaction, with signaling activity in cancer cells, and is currently being evaluated as a potential negative immune checkpoint regulatory and antineoplastic agent.
Reference:
1. Patent WO2016142886, 3-SUBSTITUTED-1,2,4-OXADIAZOLE AND THIADIAZOLE COMPOUNDS AS IMMUNOMODULATORS*Validated by a high-precision quantitative elemental analysis.
APIM050058: PD-1 INHIBITOR 16 (AURIGENE COMPOUND 16)
CAS No.: 2005454-12-4.
Molecular Formula: C14H23N7O6?H2O.
Molecular Weight: 403.4 (or refer to Certificate of Analysis, batch-specific).
Purity: >99.5% by HPLC (at 214 nm).
QC: HPLC, 1H-NMR, Quantitative Elemental Analysis Report.
Solubility: Refer to Certificate of Analysis.
Storage: Refer to Certificate of Analysis.
Copyright © 2009-2022 sydlabs.com. All rights reserved.
Use of this website means that you have read, understood, and accepted the Syd Labs Privacy Policy and Terms & Conditions.